Clinical Trials Logo

Filter by:
NCT ID: NCT06162442 Recruiting - Dry Eye Disease Clinical Trials

Management of the Ocular Surface With Preservative-Free Lubricants in Patients With Dry Eye

Start date: March 15, 2023
Phase:
Study type: Observational

Observational and prospective cohort study that seek to evaluate the epidemiological characteristics and changes in the ocular surface of patients diagnosed with dry eye disease who are treated with preservative-free lubricating drops.

NCT ID: NCT06159036 Completed - Female Clinical Trials

Effects of a Strength Training Program in Inertial Machines on Bosco Test in Youth Volleyball Players

Start date: September 26, 2022
Phase: N/A
Study type: Interventional

Objective: To determine the effect of strength training in inertial machines, on SJ CMJ and CMJ with arms; in youth volleyball players from the city of Cartago. Methodology: A quasi-experimental study of quantitative order was carried out and takes up an empirical-analytical approach, quasi-experimental with pre-test - post-test evaluation. 32 female volleyball players, belonging to the minor category of the Fénix G Club of the city of Cartago Valle Results: Both groups showed significant improvements in jump height, flight time, strength and power in the protocol that was carried out during the 12 weeks of intervention, but there was no statistically significant difference between the control groups (P = 0.356). , experimental (P = 0.984) Conclusions: Keywords: Inertial machines, Squat jump, Countermovent Jump, Abalakov

NCT ID: NCT06155006 Not yet recruiting - Clinical trials for Hepatitis C Virus Infection

Adult Screening for Hepatitis c and Linkage to Treatment in Hospitals in Colombia

HCVLINKAGE
Start date: December 11, 2023
Phase:
Study type: Observational

Introduction: Hepatitis C virus infection is a major cause of chronic hepatitis, cirrhosis, and liver cancer. The risk of developing cirrhosis for people with chronic infection with the virus ranges from 15% to 30% over a 20-year period. According to 2019 data from the World Health Organization there are 58 million people living with chronic hepatitis C infection. Three-quarters of those infected live in low- to middle-income countries, some of which lack budgets for screening, diagnosis and treatment campaigns. While good progress has been made in several countries, a significant gap in testing and treatment remains. Barriers to timely diagnosis include lack of awareness on the part of health professionals, availability and access to screening tests. Simplifying the cascade of care for this pathology would help ensure that more patients remain involved in the care pathway and ultimately achieve global goals. Objective: To estimate the prevalence of anti-HCV antibodies in patients with risk factors for hepatitis C virus captured by opportunity screening in the included hospital institutions. Methodology: Descriptive multicenter cross-sectional study. A total of 27160 participants among the seven institutions, 3880 per institution. Includes all persons over 18 years of age attended in the included health service provider institutions (IPS) who are users of hospitalization, emergency, outpatient and any other hospital care services. Application of a questionnaire to identify the inclusion criteria and data collection, signature of informed consent, sample collection by rapid test Abbott HCV rapid test - BIOLINE HCV and evaluation by tele-consultation by hepatologist principal investigator who will guide you to access the confirmatory test for HCV (viral load for Hepatitis C), the study will assume responsibility for its realization.

NCT ID: NCT06149637 Recruiting - Thyroid Cancer Clinical Trials

Lateral Cervical Node Dissection in Differentiated Thyroid Cancer.

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The objective of this study is to compare shoulder and neck morbidity and the effectiveness of cervical lateral nodal dissection in patients with differentiated thyroid cancer and lateral metastases between the anterior and posterior approaches to the sternocleidomastoid muscle (SCM)

NCT ID: NCT06146231 Recruiting - Breast Cancer Clinical Trials

Motiva Flora® Aesthetic Breast Recon® Clinical Study

Start date: August 18, 2023
Phase: N/A
Study type: Interventional

The present study will be based on a hybrid breast reconstruction approach with initial skin expansion using the Motiva Flora® Tissue Expander followed by a serial fat grafting session and a final step that includes the placement of a permanent breast implant Ergonomix2®.

NCT ID: NCT06124183 Completed - Clinical trials for Mental Health Wellness 1

Emotional Intelligence Program for Adolescents With Antisocial Behavior (DYNAMIS)

DYNAMIS
Start date: January 11, 2022
Phase: N/A
Study type: Interventional

This study assessed the effectiveness of an emotional intelligence program based on the Salovey and Mayer model among adolescents exhibiting antisocial behavior. A quasi-experimental design was employed, involving 231 Colombian adolescent offenders (122 in the experimental group). A 12-session psychological protocol was implemented. The primary question it aims to address is whether it is feasible for adolescents with antisocial behavior to reduce negative emotional symptoms related to mental health, such as anxiety, stress, and depression, while simultaneously improving their emotional skills. It was observed that those who completed the program showed significant improvements in emotional intelligence, emotional balance, and resilience while experiencing a decrease in emotional symptoms, particularly in stress.

NCT ID: NCT06118775 Not yet recruiting - Septic Shock Clinical Trials

Evaluating Dynamic Arterial Elastance in Septic Shock Patients.

EaDyn
Start date: February 1, 2024
Phase: N/A
Study type: Interventional

Assess the effectiveness and safety of using dynamic arterial elastance as a tool for weaning vasopressor support in patients with septic shock, compared to a control group

NCT ID: NCT06117891 Recruiting - Clinical trials for Unresectable Hepatocellular Carcinoma

An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery

REFINE-IO
Start date: November 27, 2023
Phase:
Study type: Observational

This is an observational study in which only data will be collected from adults with unresectable hepatocellular carcinoma. These adults should be prescribed a different treatment after treatment with atezolizumab and bevacizumab, or another similar combination of drugs, by their doctors. Unresectable hepatocellular carcinoma (uHCC) is a type of liver cancer that cannot be treated with surgery. In the past, sorafenib was the only approved first-line anti-cancer drug for people with uHCC. Regorafenib and other drugs were approved as second-line treatments for uHCC if a person could not take sorafenib or it stopped working for them. Lately, another first-line (1L) treatment called immuno-oncology (IO) immune checkpoint inhibitor combination (1L-IO combo), like atezolizumab with bevacizumab (AB), has become the preferred choice of treatment. This is because of the meaningful impact on patient survival. 1L-IO combo are drugs that help the body's defense system recognize and kill cancer cells. Since the other treatments were previously approved for use following sorafenib, the best order to take these treatments in following an 1L-IO combo is unknown. To better understand and determine this order, more knowledge is needed about how well different treatments work in participants with uHCC who have been treated with AB or another 1L-IO combo. The main purpose of this study is to learn more about how well different treatments work when given after first-line treatment with AB or another approved 1L-IO combo. To do this, researchers will collect data on how long the participants live (also called overall survival) from the start of any treatment given after the first-line treatment. In addition, researchers will also collect the following information to learn more about the participants who will be given a different treatment after the 1L-IO combo: - characteristics including age, sex, and race, and signs and symptoms of the participants over the duration of their first-line treatment - the length of time from the first to the last dose (also called duration of therapy) of the treatments given after the 1L-IO combo - the length of time until a participant's cancer worsens, or they die (also called progression free survival) from the start of the treatments given after the 1L-IO combo - the number of participants whose tumor completely disappears or shrinks (also called overall tumor response) after taking the treatments given after the 1L-IO combo - the sequence of treatments given after the 1L-IO combo Data will be collected from September 2023 to December 2026 and cover a period of around 3 years. The data will be collected using medical records or by interviewing the participants during their routine visits to the doctor. Researchers will observe participants from the start of the treatment given after the 1L-IO combo until the end of their participation in the study. In this study, only data from routine care will be collected. No visits or tests are required as part of this study.

NCT ID: NCT06111144 Enrolling by invitation - Healthy Volunteers Clinical Trials

Effects of Polarized and Pyramidal Training Combined With or Without Mindfulness in Amateur Runners

Start date: August 16, 2023
Phase: N/A
Study type: Interventional

Road running in athletics has grown worldwide in recent years, which has led to an increase in the number of recreational runners. Despite this growth, research addressing this population is scarce, with major limitations and methodological weaknesses. Two of the topics of recent interest in runners are the effects of training intensity distribution (TID) and mental training using mindfulness on running time, body composition and physiological parameters related to performance in endurance sports; the maximal oxygen consumption (VO2max), maximal aerobic speed (MAS) and ventilatory thresholds (VT). The scarce evidence found identifies the TID polarized model as the most effective in sports performance and TID pyramidal model as the most used by elite runners. For mindfulness, it is identified as an emerging program that could contribute to performance in endurance sports.

NCT ID: NCT06092294 Completed - Clinical trials for Decision Making in Soccer Players and Executive Functions

Numerical Superiority and Inferiority Compared With Conventional Training on PTK and Executive Functions in Soccer

Start date: July 3, 2023
Phase: N/A
Study type: Interventional

There is a great need to establish reliable evaluation and intervention protocols to improve the tactical component, decision making (DM) and procedural tactical knowledge (PTK) in soccer. Objectives: to determine the effects of a 12-week follow up numerical superiority and numerical inferiority tactical training program on PTK, which will be evaluated by calculating offensive, defensive and global effectiveness indexes (EI) of 24 amateur male soccer players, as well as the effect on their executive functions. Method: randomized controlled trial, with two groups in parallel, experimental group (EG) and control group (CG), with different measurements over time (pretest, intermediate test 1, intermediate test 2 and posttest).